INTCO MEDICAL(SZ:300677) Orient Securities·2026-03-07 10:25Investment Rating - The report gives a "Buy" rating for the company for the first time, with a target price of 53.46 CNY based on an 18x P/E ratio for 2026 [4][7]. Core Insights - The company is positioned as a leader in the disposable glove market, with a strong focus on cost advantages and advanced production lines, which are expected to enhance its market share as the industry stabilizes post-pandemic [10][26]. - The company has a robust financial outlook, with projected earnings per share of 1.98 CNY, 2.97 CNY, and 3.37 CNY for 2025, 2026, and 2027 respectively [4][28]. Financial Summary - Revenue is expected to grow from 6,919 million CNY in 2023 to 13,563 million CNY in 2027, with a CAGR of 36% from 2019 to 2024 [6][28]. - The net profit attributable to the parent company is projected to increase from 383 million CNY in 2023 to 2,209 million CNY in 2027, reflecting a significant recovery post-pandemic [6][28]. - The gross margin is expected to improve from 13.7% in 2023 to 25.6% in 2027, indicating enhanced operational efficiency [6][28]. Market Position and Strategy - The company has established a strong presence in over 120 countries, with 84.7% of its revenue coming from overseas markets in 2024 [10][23]. - The production capacity has significantly increased, with a 233.2% growth from 2019 to 2024, positioning the company among the top players globally [33][34]. - The company is leveraging advanced production lines that are energy-efficient and have a high yield rate of over 99%, which contributes to its competitive edge [48][52]. Cost Structure and Efficiency - The company has implemented energy-saving technologies and has a strong focus on controlling raw material costs, which are critical for maintaining its competitive pricing [55][60]. - The cost of direct materials and outsourced costs is the highest among its peers, indicating a strategic focus on optimizing production costs [55][63]. - The company is also investing in upstream raw material production to mitigate cost fluctuations and ensure supply stability [61][65].